Aug 17, 2023 8:30am EDT RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
Jul 20, 2023 8:00am EDT RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
Jun 29, 2023 8:00am EDT RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
Jun 01, 2023 8:30am EDT RenovoRx Initiates Patient Enrollment at University of Texas Southwestern Medical Center for Pivotal Phase III TIGeR-PaC Clinical Trial
May 25, 2023 8:30am EDT RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer
May 15, 2023 8:30am EDT RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
